#optpace resultados de búsqueda

#EHRA2019 The #OPTPACE Trial- Optimising pacemaker & medical therapy in #pacemaker pts for HF. 1/3 patients with pacemaker have LVEF<%50. #Echocardiography doesn’t improve outcomes. #Heartfailure clinic lead to optimal medical therapy.

ahmetilker1's tweet image. #EHRA2019 The #OPTPACE Trial- Optimising pacemaker &amp;amp; medical therapy in #pacemaker pts for HF. 1/3 patients with pacemaker have LVEF&amp;lt;%50. #Echocardiography doesn’t improve outcomes. #Heartfailure clinic lead to optimal medical therapy.
ahmetilker1's tweet image. #EHRA2019 The #OPTPACE Trial- Optimising pacemaker &amp;amp; medical therapy in #pacemaker pts for HF. 1/3 patients with pacemaker have LVEF&amp;lt;%50. #Echocardiography doesn’t improve outcomes. #Heartfailure clinic lead to optimal medical therapy.
ahmetilker1's tweet image. #EHRA2019 The #OPTPACE Trial- Optimising pacemaker &amp;amp; medical therapy in #pacemaker pts for HF. 1/3 patients with pacemaker have LVEF&amp;lt;%50. #Echocardiography doesn’t improve outcomes. #Heartfailure clinic lead to optimal medical therapy.
ahmetilker1's tweet image. #EHRA2019 The #OPTPACE Trial- Optimising pacemaker &amp;amp; medical therapy in #pacemaker pts for HF. 1/3 patients with pacemaker have LVEF&amp;lt;%50. #Echocardiography doesn’t improve outcomes. #Heartfailure clinic lead to optimal medical therapy.

Screening for #HF and optimising care pathways for people with #pacemakers #OPTPACE LBCT results at #ESCCongress HFH/all-cause mortality ⬇️ in ppm recipients with TTE + Combined HF and Device care compared to TTE-guided primary care: 12% vs 24% @NIHRresearch @LeedsMedHealth

paton_maria's tweet image. Screening for #HF and optimising care pathways for people with #pacemakers #OPTPACE LBCT results at #ESCCongress 

HFH/all-cause mortality ⬇️ in ppm recipients with TTE + Combined HF and Device care compared to TTE-guided primary care: 12% vs 24%
@NIHRresearch @LeedsMedHealth
paton_maria's tweet image. Screening for #HF and optimising care pathways for people with #pacemakers #OPTPACE LBCT results at #ESCCongress 

HFH/all-cause mortality ⬇️ in ppm recipients with TTE + Combined HF and Device care compared to TTE-guided primary care: 12% vs 24%
@NIHRresearch @LeedsMedHealth
paton_maria's tweet image. Screening for #HF and optimising care pathways for people with #pacemakers #OPTPACE LBCT results at #ESCCongress 

HFH/all-cause mortality ⬇️ in ppm recipients with TTE + Combined HF and Device care compared to TTE-guided primary care: 12% vs 24%
@NIHRresearch @LeedsMedHealth
paton_maria's tweet image. Screening for #HF and optimising care pathways for people with #pacemakers #OPTPACE LBCT results at #ESCCongress 

HFH/all-cause mortality ⬇️ in ppm recipients with TTE + Combined HF and Device care compared to TTE-guided primary care: 12% vs 24%
@NIHRresearch @LeedsMedHealth

That feeling after recruiting the final patient to a large portfolio #multicentre #RCT #OPTpace @UniversityLeeds @OfficialNIHR @lthtresearch


What a day! I am so incredibly proud to see the #OPTPACE manuscript in the flesh! This study began my #clinicalacademic career; and has directly led to my work with the combined heart failure and device service @LeedsHospitals @cardiorespLTHT and @NIHRresearch

Does #echocardiography screening for #HF in a #pacemaker population improve clinical outcomes? See our paper @NatureMedicine - only when delivered by specialised integrated #heartfailure and devices clinic. nature.com/articles/s4159…

KlausKWitte's tweet image. Does #echocardiography screening for #HF in a #pacemaker population improve clinical outcomes?
  
See our paper @NatureMedicine - only when delivered by specialised integrated #heartfailure and devices clinic.  

nature.com/articles/s4159…


Agreed! Our study #OPTPACE prelim results show HF med optimisation is much better in specialist #heartfailure in-hospital clinics than primary care for pacemaker patients. I think the key is having specialised multidisciplinary care wherever that is! #cardiology #cardiacscientist


Miss #EHRA2019? Here’s a summary of our #OPTPACE RCT on value of #echo +medical optimisation in #pacemaker pts. Key is if LVSD diagnosed #heartfailure meds optimally achieved in #HF clinic! ⁦@UniversityLeeds⁩ ⁦@lthtresearch⁩ ⁦@escardioradcliffecardiology.com/gallery/ehra-1…


#latebreaking trial update #ESCCongress23 #OPTPACE Screening for #heartfailure in patients with pacemakers improves clinical outcomes ❗️❗️ But ONLY when implemented as part of a combined heart failure and device service @KlausKWitte @paton_maria @escardio @JohnGierula

Screening for #HF and optimising care pathways for people with #pacemakers #OPTPACE LBCT results at #ESCCongress HFH/all-cause mortality ⬇️ in ppm recipients with TTE + Combined HF and Device care compared to TTE-guided primary care: 12% vs 24% @NIHRresearch @LeedsMedHealth

paton_maria's tweet image. Screening for #HF and optimising care pathways for people with #pacemakers #OPTPACE LBCT results at #ESCCongress 

HFH/all-cause mortality ⬇️ in ppm recipients with TTE + Combined HF and Device care compared to TTE-guided primary care: 12% vs 24%
@NIHRresearch @LeedsMedHealth
paton_maria's tweet image. Screening for #HF and optimising care pathways for people with #pacemakers #OPTPACE LBCT results at #ESCCongress 

HFH/all-cause mortality ⬇️ in ppm recipients with TTE + Combined HF and Device care compared to TTE-guided primary care: 12% vs 24%
@NIHRresearch @LeedsMedHealth
paton_maria's tweet image. Screening for #HF and optimising care pathways for people with #pacemakers #OPTPACE LBCT results at #ESCCongress 

HFH/all-cause mortality ⬇️ in ppm recipients with TTE + Combined HF and Device care compared to TTE-guided primary care: 12% vs 24%
@NIHRresearch @LeedsMedHealth
paton_maria's tweet image. Screening for #HF and optimising care pathways for people with #pacemakers #OPTPACE LBCT results at #ESCCongress 

HFH/all-cause mortality ⬇️ in ppm recipients with TTE + Combined HF and Device care compared to TTE-guided primary care: 12% vs 24%
@NIHRresearch @LeedsMedHealth


Love this slide from #ACC16 just what the aim of #OPTpace is

Cardiologists should save this slide as their wallpaper on their iPhone #acc16. Think burden of care!

drjohnm's tweet image. Cardiologists should save this slide as their wallpaper on their iPhone #acc16. Think burden of care!


Full crowd to see the Late Breaking Clinical Trials at Rembrandt at -#ESCCongress! Looking forward to @KlausKWitte presenting our #OPTPACE results next!


Wednesday #OPTpace day! Today I'm teaching my #patients about their new #pacemakers #patienteducation #research


Recruiting for #OPTpace today! #pacemaker patients are so willing to give back and be involved in #research


@unileedscardio into our last 75 recruits for an #OPTpace arm @LTHTrust going be a fantastic study of #pacemaker patients #clinicalreseach


5 pts remaining to recruit to #OPTpace #Leeds - total of over 1650 #pacemaker patients! Great #research cohort @lthtresearch @OfficialNIHR


Ready for my #OPTpace #research clinic @HDFT_Innovation in cardiology. #pacemaker patients are so willing to help here, it's lovely!


Had a great day today visiting @BTHFT as a site for the #OPTpace #pacemaker study. What a great team and lovely hospital! #clinicalresearch


Hold $OPT if you want A TOKEN WITH ACTION UTILITY tied to social, streaming, payments and commerce. optio.community #OPT #Parler #Crypto

Optiocommunity's tweet image. Hold $OPT if you want A TOKEN WITH ACTION UTILITY tied to social, streaming, payments and commerce.

optio.community

#OPT #Parler #Crypto

OPT is being exploited as the F>OPT>H1B>GC "hack" that discriminates against American grads, & gives the visa holder privileges to work inside the US while waiting for a GC instead of outside the US like all other visa applicants. It's unfair & it needs to be shut down. @POTUS


OPT is outright sadistic. Creating a pipeline of replacement workers parallel to American students. Their own international classmates will graduate with jobs while they get stuck "holding the bag."


The base needs red meat. Please get Trump to end OPT, it's only in effect by executive fiat. You know how dire it is


thats OPT which is even worse and could be ended by executive order


$OPT powers the blockchain behind Pulse, Parler, Kyvo, Cartix, Jedari, and much much more.

Optio powers the entire Parler ecosystem and Kyvo takes it further with crypto and fiat in one wallet. Store thousands of ERC-20 tokens. Move value across Parler, PlayTV and Cartix without friction. optio.community #Optio #Kyvo #Web3 #PulseEcosystem



$OPT is the utility token built for scale across social, video and commerce. optio.community


OPT is now listed on MEXC. This gives you direct access to the only token tied to a full working ecosystem. OPT powers Parler, PlayTV, Kyvo and Cartix. It drives payments, rewards and real utility across platforms built for scale. Trade OPT on MEXC and join the growth.…


@OptioBlockchain @Optiocommunity $OPT is now on @MEXC_Official @MEXC_Listings @MEXC_Japan for trading!! Looking to earn the token from rewards download @getparlerapp @getplaytv and @getkyvo the super wallet! Free speech premier ! ! !


Since yesterday night, the OPT's been saying "invalid/expired OTP"


Optare can be linked to optics as seeing ahead and desiring more 🤔


Yes! You are listening. 👍 Thank you. Keep fighting and we’ll support you all the way to the WH, eventually. Trump can and should end OPT immediately via EO. @realDonaldTrump @JDVance @GOP


OPT...OPT is the weakest link of all. No OPT, the F1 pipeline collapses. No OPT and the H1B collapses. The great thing is: OPT was never a Congressional thing. It was a pure DHS move and can be removed by Trump through an EO.


And the #OPT token is off to the races on @MEXC_Official this morning Do not forget to download @getparlerapp and @getplaytv to engage and @getkyvo to store and #stakje your tokens and earn rewards! #blockchain made easy for the people ! ! !

NFT_Addictz's tweet image. And the #OPT token is off to the races on @MEXC_Official this morning 

Do not forget to download @getparlerapp and @getplaytv to engage and @getkyvo to store and #stakje your tokens and earn rewards! 

#blockchain made easy for the people ! ! !

In some sense, this is worse than H1B, which can be cleaned up over time with oversight. OPT, as it is, incentivizes universities to sell access to the US labor market through degrees. Sick business. It also steals jobs from our best men.


Exactly, OPT is essentially a loophole exploited to bring in cheap foreign labor under the guise of student training. Unlike H-1B, which requires congressional authorization, OPT was created administratively, so it’s more easily revocable if the administration decides to act


There are programs besides just H-1B that need to also be cancelled. OPT (Optical Practical Training) allows cheap foreign labor of international students to work during and after graduation. 500,000+ are active now. Congress never created it. Bureaucrats did. Trump can end it.

The Optional Practical Training program is a cheap foreign-labor program for big companies and universities. But it's undermining young Americans. It’s time to overhaul or possibly end this terribly broken program all together. 🧵

Eric_Schmitt's tweet image. The Optional Practical Training program is a cheap foreign-labor program for big companies and universities.

But it&apos;s undermining young Americans.

It’s time to overhaul or possibly end this terribly broken program all together. 🧵


OPT is entirely an executive choice item. Congress never authorized it. It's still going because Trump wants it to be


[TwiPla] 11/15(土) OPT - オーギリポーカーツアー Vol.4 twipla.jp/events/700218 こんなに天気がいい日は、やっぱり「OPT」で決まり!


No hay resultados para "#optpace"

#EHRA2019 The #OPTPACE Trial- Optimising pacemaker & medical therapy in #pacemaker pts for HF. 1/3 patients with pacemaker have LVEF<%50. #Echocardiography doesn’t improve outcomes. #Heartfailure clinic lead to optimal medical therapy.

ahmetilker1's tweet image. #EHRA2019 The #OPTPACE Trial- Optimising pacemaker &amp;amp; medical therapy in #pacemaker pts for HF. 1/3 patients with pacemaker have LVEF&amp;lt;%50. #Echocardiography doesn’t improve outcomes. #Heartfailure clinic lead to optimal medical therapy.
ahmetilker1's tweet image. #EHRA2019 The #OPTPACE Trial- Optimising pacemaker &amp;amp; medical therapy in #pacemaker pts for HF. 1/3 patients with pacemaker have LVEF&amp;lt;%50. #Echocardiography doesn’t improve outcomes. #Heartfailure clinic lead to optimal medical therapy.
ahmetilker1's tweet image. #EHRA2019 The #OPTPACE Trial- Optimising pacemaker &amp;amp; medical therapy in #pacemaker pts for HF. 1/3 patients with pacemaker have LVEF&amp;lt;%50. #Echocardiography doesn’t improve outcomes. #Heartfailure clinic lead to optimal medical therapy.
ahmetilker1's tweet image. #EHRA2019 The #OPTPACE Trial- Optimising pacemaker &amp;amp; medical therapy in #pacemaker pts for HF. 1/3 patients with pacemaker have LVEF&amp;lt;%50. #Echocardiography doesn’t improve outcomes. #Heartfailure clinic lead to optimal medical therapy.

That feeling after recruiting the final patient to a large portfolio #multicentre #RCT #OPTpace @UniversityLeeds @OfficialNIHR @lthtresearch


Screening for #HF and optimising care pathways for people with #pacemakers #OPTPACE LBCT results at #ESCCongress HFH/all-cause mortality ⬇️ in ppm recipients with TTE + Combined HF and Device care compared to TTE-guided primary care: 12% vs 24% @NIHRresearch @LeedsMedHealth

paton_maria's tweet image. Screening for #HF and optimising care pathways for people with #pacemakers #OPTPACE LBCT results at #ESCCongress 

HFH/all-cause mortality ⬇️ in ppm recipients with TTE + Combined HF and Device care compared to TTE-guided primary care: 12% vs 24%
@NIHRresearch @LeedsMedHealth
paton_maria's tweet image. Screening for #HF and optimising care pathways for people with #pacemakers #OPTPACE LBCT results at #ESCCongress 

HFH/all-cause mortality ⬇️ in ppm recipients with TTE + Combined HF and Device care compared to TTE-guided primary care: 12% vs 24%
@NIHRresearch @LeedsMedHealth
paton_maria's tweet image. Screening for #HF and optimising care pathways for people with #pacemakers #OPTPACE LBCT results at #ESCCongress 

HFH/all-cause mortality ⬇️ in ppm recipients with TTE + Combined HF and Device care compared to TTE-guided primary care: 12% vs 24%
@NIHRresearch @LeedsMedHealth
paton_maria's tweet image. Screening for #HF and optimising care pathways for people with #pacemakers #OPTPACE LBCT results at #ESCCongress 

HFH/all-cause mortality ⬇️ in ppm recipients with TTE + Combined HF and Device care compared to TTE-guided primary care: 12% vs 24%
@NIHRresearch @LeedsMedHealth

Loading...

Something went wrong.


Something went wrong.


United States Trends